9122B |
Bupropion and Metabolite Screen, Blood |
9122SP |
Bupropion and Metabolite Screen, Serum/Plasma |
9122TI |
Bupropion and Metabolite Screen, Tissue |
9122U |
Bupropion and Metabolite Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9329B |
Benzodiazepines Panel, Blood |
9329FL |
Benzodiazepines Panel, Fluid |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9329SP |
Benzodiazepines Panel, Serum/Plasma |
9329TI |
Benzodiazepines Panel, Tissue |
9329U |
Benzodiazepines Panel, Urine |
9341B |
Flunitrazepam and Metabolites Screen, Blood |
9341SP |
Flunitrazepam and Metabolites Screen, Serum/Plasma |
9341TI |
Flunitrazepam and Metabolites Screen, Tissue |
9341U |
Flunitrazepam and Metabolites Screen, Urine |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9447B |
Venlafaxine and Metabolite Screen, Blood |
9447U |
Venlafaxine and Metabolite Screen, Urine |